1/30/2018WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing C...

1/30/2018CFDA Lays Out Eight Major Food and Drug Regulatory Tasks in 2018

1/30/2018AmCham: U.S. Cos in China Increasingly Upbeat on Economy Despite Ongoi...

1/30/2018CFDA and MOST Issue Joint Document for Promoting Food and Drug Innovat...

1/30/2018Compliance in China: Key Considerations

1/29/2018CFDA Issues First List of Drugs with Expired, Terminated or Invalidate...

1/29/2018NHFPC Solicits Feedbacks on Proposed Measure to Eliminate Provisions i...

1/25/2018CFDA Issues New Announcement (2018#9) for Clinical Data Self-Inspectio...

1/25/2018Shanghai Pharma to Open R&D Unit in San Diego As It Looks for More...

1/25/2018CFDA Issues Announcement on Applicability of Level 2 Guidelines of ICH

1/25/2018China Issues New Policy to Reform GP Training and Incentive Mechanisms

1/25/2018CFDA Issues the Technical Guidelines for Applications of Phase I New D...

1/23/2018China Approves Numerous Reform Policies Including New Document for Gen...

1/23/2018Ping An Ventures Led $100M Series A Financing for Cell Therapy Firm Tm...

1/23/2018Clover Biopharma to Make Biosimilars in China with GE Facility

1/23/2018Cardiome Announces Expanded Label for Aggrastat in China

1/23/2018GSK Launches Triple-threapy HIV Drug Triumeq in Mainland China with Co...

1/23/2018IQVIA: Chinese Hospital Drug Sales Up 6.2% in Q3/2017

1/23/2018IQVIA: Chinese Retail Pharmacy Sales Up 2. 6% in MAT Q3/2017

1/22/2018USTR's 2017 Report for China's WTO Compliance Highlight IP Issues in P...

1/19/2018118 Listed Chinese Pharma Cos Report 2017 Performance Guidance

1/19/2018Recent Executive Moves

1/19/2018Ascletis Seeks Third Round of Funding That Could Exceed US$100M

1/19/2018Made in China: New and Potentially Lifesaving Drugs

1/19/2018Mundipharma to Take Over Marketing of Grunenthal's Pain-Relief Drug in...

1/19/2018CFDA Approves New Indication of Mitsubishi Tanabe's Novastan

1/19/2018CITIC Capital Becomes Controlling Shareholder of Harbin Pharma

1/18/2018EMA Bans Amoxicillin API from Changsheng Pharma after Identifying Defi...

1/18/2018Hua Medicine Mulls Hong Kong IPO as Diabetes Drug Enters Crucial Clini...

1/18/2018Xbrane, CR Pharma Sign Letter of Intent for Lucentis Biosimilar in Chi...

Page:146/334 Total number of articles:10001: [First][<<] [144] [145] [146] [147] [148] [>>] [End]